BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24080446)

  • 1. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
    Rudolph A; Hein R; Lindström S; Beckmann L; Behrens S; Liu J; Aschard H; Bolla MK; Wang J; Truong T; Cordina-Duverger E; Menegaux F; Brüning T; Harth V; ; Severi G; Baglietto L; Southey M; Chanock SJ; Lissowska J; Figueroa JD; Eriksson M; Humpreys K; Darabi H; Olson JE; Stevens KN; Vachon CM; Knight JA; Glendon G; Mulligan AM; Ashworth A; Orr N; Schoemaker M; Webb PM; ; ; Guénel P; Brauch H; Giles G; García-Closas M; Czene K; Chenevix-Trench G; Couch FJ; Andrulis IL; Swerdlow A; Hunter DJ; Flesch-Janys D; Easton DF; Hall P; Nevanlinna H; Kraft P; Chang-Claude J;
    Endocr Relat Cancer; 2013 Dec; 20(6):875-87. PubMed ID: 24080446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.
    Hein R; Flesch-Janys D; Dahmen N; Beckmann L; Lindström S; Schoof N; Czene K; Mittelstraß K; Illig T; Seibold P; Behrens S; Humphreys K; Li J; Liu J; Olson JE; Wang X; Hankinson SE; Truong T; Menegaux F; Dos Santos Silva I; Johnson N; ; Chen ST; Yu JC; Ziogas A; Kataja V; Kosma VM; Mannermaa A; Anton-Culver H; Shen CY; Brauch H; Peto J; Guénel P; Kraft P; Couch FJ; Easton DF; Hall P; Chang-Claude J
    Breast Cancer Res Treat; 2013 Apr; 138(2):529-542. PubMed ID: 23423446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.
    Rudolph A; Fasching PA; Behrens S; Eilber U; Bolla MK; Wang Q; Thompson D; Czene K; Brand JS; Li J; Scott C; Pankratz VS; Brandt K; Hallberg E; Olson JE; Lee A; Beckmann MW; Ekici AB; Haeberle L; Maskarinec G; Le Marchand L; Schumacher F; Milne RL; Knight JA; Apicella C; Southey MC; Kapuscinski MK; Hopper JL; Andrulis IL; Giles GG; Haiman CA; Khaw KT; Luben R; Hall P; Pharoah PD; Couch FJ; Easton DF; Dos-Santos-Silva I; Vachon C; Chang-Claude J
    Breast Cancer Res; 2015 Aug; 17(1):110. PubMed ID: 26275715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.
    Wang X; Kapoor PM; Auer PL; Dennis J; Dunning AM; Wang Q; Lush M; Michailidou K; Bolla MK; Aronson KJ; Murphy RA; Brooks-Wilson A; Lee DG; Cordina-Duverger E; Guénel P; Truong T; Mulot C; Teras LR; Patel AV; Dossus L; Kaaks R; Hoppe R; Lo WY; Brüning T; Hamann U; Czene K; Gabrielson M; Hall P; Eriksson M; Jung A; Becher H; Couch FJ; Larson NL; Olson JE; Ruddy KJ; Giles GG; MacInnis RJ; Southey MC; Le Marchand L; Wilkens LR; Haiman CA; Olsson H; Augustinsson A; Krüger U; Wagner P; Scott C; Winham SJ; Vachon CM; Perou CM; Olshan AF; Troester MA; Hunter DJ; Eliassen HA; Tamimi RM; Brantley K; Andrulis IL; Figueroa J; Chanock SJ; Ahearn TU; García-Closas M; Evans GD; Newman WG; van Veen EM; Howell A; Wolk A; Håkansson N; Anton-Culver H; Ziogas A; Jones ME; Orr N; Schoemaker MJ; Swerdlow AJ; Kitahara CM; Linet M; Prentice RL; Easton DF; Milne RL; Kraft P; Chang-Claude J; Lindström S
    Sci Rep; 2022 Apr; 12(1):6199. PubMed ID: 35418701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors.
    Rudolph A; Milne RL; Truong T; Knight JA; Seibold P; Flesch-Janys D; Behrens S; Eilber U; Bolla MK; Wang Q; Dennis J; Dunning AM; Shah M; Munday HR; Darabi H; Eriksson M; Brand JS; Olson J; Vachon CM; Hallberg E; Castelao JE; Carracedo A; Torres M; Li J; Humphreys K; Cordina-Duverger E; Menegaux F; Flyger H; Nordestgaard BG; Nielsen SF; Yesilyurt BT; Floris G; Leunen K; Engelhardt EG; Broeks A; Rutgers EJ; Glendon G; Mulligan AM; Cross S; Reed M; Gonzalez-Neira A; Arias Perez JI; Provenzano E; Apicella C; Southey MC; Spurdle A; ; ; Häberle L; Beckmann MW; Ekici AB; Dieffenbach AK; Arndt V; Stegmaier C; McLean C; Baglietto L; Chanock SJ; Lissowska J; Sherman ME; Brüning T; Hamann U; Ko YD; Orr N; Schoemaker M; Ashworth A; Kosma VM; Kataja V; Hartikainen JM; Mannermaa A; Swerdlow A; ; Giles GG; Brenner H; Fasching PA; Chenevix-Trench G; Hopper J; Benítez J; Cox A; Andrulis IL; Lambrechts D; Gago-Dominguez M; Couch F; Czene K; Bojesen SE; Easton DF; Schmidt MK; Guénel P; Hall P; Pharoah PD; Garcia-Closas M; Chang-Claude J
    Int J Cancer; 2015 Mar; 136(6):E685-96. PubMed ID: 25227710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
    Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
    Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.
    Mhatre S; Wang Z; Nagrani R; Badwe R; Chiplunkar S; Mittal B; Yadav S; Zhang H; Chung CC; Patil P; Chanock S; Dikshit R; Chatterjee N; Rajaraman P
    Lancet Oncol; 2017 Apr; 18(4):535-544. PubMed ID: 28274756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
    Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
    Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
    Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
    Bensen JT; Graff M; Young KL; Sethupathy P; Parker J; Pecot CV; Currin K; Haddad SA; Ruiz-Narváez EA; Haiman CA; Hong CC; Sucheston-Campbell LE; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Lunetta KL; Ambrosone CB; Palmer JR; Troester MA; Olshan AF
    Breast Cancer Res; 2018 Jun; 20(1):45. PubMed ID: 29871690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium.
    Kapoor PM; Lindström S; Behrens S; Wang X; Michailidou K; Bolla MK; Wang Q; Dennis J; Dunning AM; Pharoah PDP; Schmidt MK; Kraft P; García-Closas M; Easton DF; Milne RL; Chang-Claude J;
    Int J Epidemiol; 2020 Feb; 49(1):216-232. PubMed ID: 31605532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
    Sawyer E; Roylance R; Petridis C; Brook MN; Nowinski S; Papouli E; Fletcher O; Pinder S; Hanby A; Kohut K; Gorman P; Caneppele M; Peto J; Dos Santos Silva I; Johnson N; Swann R; Dwek M; Perkins KA; Gillett C; Houlston R; Ross G; De Ieso P; Southey MC; Hopper JL; Provenzano E; Apicella C; Wesseling J; Cornelissen S; Keeman R; Fasching PA; Jud SM; Ekici AB; Beckmann MW; Kerin MJ; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Kerbrat P; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Perez JI; Menéndez P; Benitez J; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Meindl A; Lichtner P; Schmutzler RK; Lochmann M; Brauch H; Fischer HP; Ko YD; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova NV; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; ; Lambrechts D; Weltens C; Van Limbergen E; Hatse S; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Volorio S; Giles GG; Severi G; Baglietto L; McLean CA; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Kristensen V; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Devillee P; Tollenaar RA; Seynaeve CM; Kriege M; Figueroa J; Chanock SJ; Sherman ME; Hooning MJ; Hollestelle A; van den Ouweland AM; van Deurzen CH; Li J; Czene K; Humphreys K; Cox A; Cross SS; Reed MW; Shah M; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Swerdlow A; Ashworth A; Orr N; Schoemaker M; Couch FJ; Hallberg E; González-Neira A; Pita G; Alonso MR; Tessier DC; Vincent D; Bacot F; Bolla MK; Wang Q; Dennis J; Michailidou K; Dunning AM; Hall P; Easton D; Pharoah P; Schmidt MK; Tomlinson I; Garcia-Closas M
    PLoS Genet; 2014 Apr; 10(4):e1004285. PubMed ID: 24743323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
    Shaker OG; Senousy MA
    Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy and risk of clinical breast cancer subtypes.
    Slanger TE; Chang-Claude JC; Obi N; Kropp S; Berger J; Vettorazzi E; Braendle W; Bastert G; Hentschel S; Flesch-Janys D
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1188-96. PubMed ID: 19336542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
    Barrdahl M; Canzian F; Joshi AD; Travis RC; Chang-Claude J; Auer PL; Gapstur SM; Gaudet M; Diver WR; Henderson BE; Haiman CA; Schumacher FR; Le Marchand L; Berg CD; Chanock SJ; Hoover RN; Rudolph A; Ziegler RG; Giles GG; Baglietto L; Severi G; Hankinson SE; Lindström S; Willet W; Hunter DJ; Buring JE; Lee IM; Zhang S; Dossus L; Cox DG; Khaw KT; Lund E; Naccarati A; Peeters PH; Quirós JR; Riboli E; Sund M; Trichopoulos D; Prentice RL; Kraft P; Kaaks R; Campa D
    Hum Mol Genet; 2014 Oct; 23(19):5260-70. PubMed ID: 24895409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium.
    Gaudet MM; Barrdahl M; Lindström S; Travis RC; Auer PL; Buring JE; Chanock SJ; Eliassen AH; Gapstur SM; Giles GG; Gunter M; Haiman C; Hunter DJ; Joshi AD; Kaaks R; Khaw KT; Lee IM; Le Marchand L; Milne RL; Peeters PH; Sund M; Tamimi R; Trichopoulou A; Weiderpass E; Yang XR; Prentice RL; Feigelson HS; Canzian F; Kraft P
    Breast Cancer Res Treat; 2016 Feb; 155(3):531-40. PubMed ID: 26802016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
    Kerns SL; Stock R; Stone N; Buckstein M; Shao Y; Campbell C; Rath L; De Ruysscher D; Lammering G; Hixson R; Cesaretti J; Terk M; Ostrer H; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e21-8. PubMed ID: 23021708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.
    Ahsan H; Halpern J; Kibriya MG; Pierce BL; Tong L; Gamazon E; McGuire V; Felberg A; Shi J; Jasmine F; Roy S; Brutus R; Argos M; Melkonian S; Chang-Claude J; Andrulis I; Hopper JL; John EM; Malone K; Ursin G; Gammon MD; Thomas DC; Seminara D; Casey G; Knight JA; Southey MC; Giles GG; Santella RM; Lee E; Conti D; Duggan D; Gallinger S; Haile R; Jenkins M; Lindor NM; Newcomb P; Michailidou K; Apicella C; Park DJ; Peto J; Fletcher O; dos Santos Silva I; Lathrop M; Hunter DJ; Chanock SJ; Meindl A; Schmutzler RK; Müller-Myhsok B; Lochmann M; Beckmann L; Hein R; Makalic E; Schmidt DF; Bui QM; Stone J; Flesch-Janys D; Dahmen N; Nevanlinna H; Aittomäki K; Blomqvist C; Hall P; Czene K; Irwanto A; Liu J; Rahman N; Turnbull C; ; Dunning AM; Pharoah P; Waisfisz Q; Meijers-Heijboer H; Uitterlinden AG; Rivadeneira F; Nicolae D; Easton DF; Cox NJ; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):658-69. PubMed ID: 24493630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.